Modern management of hypertension and heart failure: evidence and practice.
作者信息
Hobbs F D
机构信息
Division of Primary Care, Public and Occupational Health, University of Birmingham, Birmingham B15 2TT, UK.
出版信息
Heart. 2000 Sep;84 Suppl 1(Suppl 1):i35-8; discussion i50. doi: 10.1136/heart.84.suppl_1.i35.
Abstract
摘要
相似文献
1
Modern management of hypertension and heart failure: evidence and practice.
Heart. 2000 Sep;84 Suppl 1(Suppl 1):i35-8; discussion i50. doi: 10.1136/heart.84.suppl_1.i35.
2
Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?
J Gen Intern Med. 1997 Sep;12(9):581-2. doi: 10.1046/j.1525-1497.1997.07147.x.
3
Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
Int J Cardiol. 1997 Mar;59(1):7-10. doi: 10.1016/s0167-5273(96)02904-x.
4
[Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose].
Med Clin (Barc). 2000;114 Suppl 2:24-7.
5
[ACE inhibitors--an overview].
Fortschr Med. 1993 Jun 10;111(16):283-5.
6
Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Lancet Glob Health. 2018 Sep;6(9):e1008-e1018. doi: 10.1016/S2214-109X(18)30306-1.
7
Underutilisation of ACE inhibitors in patients with congestive heart failure.
Drugs. 2001;61(14):2021-33. doi: 10.2165/00003495-200161140-00002.
8
Diagnosis and management of chronic heart failure: how to reestablish a key role for the primary care physician?
Acta Clin Belg. 2004 Sep-Oct;59(5):300-3. doi: 10.1179/acb.2004.044.
9
Angiotensin-converting enzyme inhibitors in congestive heart failure.
West J Med. 1995 Jul;163(1):67.
10
[Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
Rev Esp Cardiol. 1995 Feb;48(2):128-41.
引用本文的文献
1
Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK.
J R Soc Med. 2003 Nov;96(11):525-31. doi: 10.1177/014107680309601104.
本文引用的文献
1
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.
Circulation. 1999 Dec 7;100(23):2312-8. doi: 10.1161/01.cir.100.23.2312.
2
Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.
J Hum Hypertens. 1999 Sep;13(9):569-92. doi: 10.1038/sj.jhh.1000917.
3
Incidence and aetiology of heart failure; a population-based study.
Eur Heart J. 1999 Mar;20(6):421-8. doi: 10.1053/euhj.1998.1280.
4
The global burden of disease, 1990-2020.
Nat Med. 1998 Nov;4(11):1241-3. doi: 10.1038/3218.
5
Blood pressure screening, management and control in England: results from the health survey for England 1994.
J Hypertens. 1998 Jun;16(6):747-52. doi: 10.1097/00004872-199816060-00005.
6
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.
Lancet. 1998 Jun 13;351(9118):1755-62. doi: 10.1016/s0140-6736(98)04311-6.
7
Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
Int J Cardiol. 1997 Mar;59(1):7-10. doi: 10.1016/s0167-5273(96)02904-x.
8
New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.
J Hum Hypertens. 1996 Jan;10(1):1-8.
9
Evidence of inadequate investigation and treatment of patients with heart failure.
Br Heart J. 1994 Jun;71(6):584-7. doi: 10.1136/hrt.71.6.584.
10
Validity of clinical diagnosis of heart failure in primary health care.
Eur Heart J. 1991 Mar;12(3):315-21. doi: 10.1093/oxfordjournals.eurheartj.a059896.
Zotero 插件